AMSA Pharm-free Scorecard 2016
Liquid error: undefined method `respond_to_missing?' for #<Liquid::Strainer:0x00000006f6a490> Yale School of Medicine
City: New Haven State: CT
Links:

Updates: This institution's COI policies were evaluated on Jun- 3-2014.

This institution's policies were found via online web searches for the 2016 Scorecard. They were last updated prior to their review for the 2014 Scorecard.

Gifts pie2

Gifts are generally prohibited, but educational gifts such as textbooks are allowed when distributed through a department.

[Domain Location: Policy 1, p 2]
Meals pie2

No industry-funded meals of any nature or value allowed except in the context of industry funded ACCME-accredited CME.

[Domain Location: Policy 1, p 3]
Industry-funded promotional speaking relationships (not ACCME-accredited) pie3

If a talk is funded by industry, the content must be determined by the speaker and not the company, and the talk must be educational and scientific in content.

[Domain Location: Policy 1, p 6]
Industry-support of ACCME-accredited CME pie1

While there is a central office for CME which is the exclusive accreditor of CME programs at Yale, there is no stipulation that industry funds go directly to the CME office rather than to departments or divisions.

[Domain Location: Policy 1, p 5]
Attendance of industry-sponsored promotional events pie3

Clinical Personnel should not attend or participate in industry-sponsored off campus events for primarily promotional/marketing purposes.' In addition, attendees may not accept travel reimbursement for other compensation for attending any industry sponsor

[Domain Location: Policy 1, p 7]
Industry-supported scholarships and awards pie2

Industry may provide scholarships to students and trainees for meeting attendance, but it may not participate in the selection of attendees, and all funds must be provided to the university and not directly to the trainee.

[Domain Location: Policy 1, p 7]
Ghostwriting and honorary authorships pie3

Ghostwriting and honorary authorship are strictly prohibited.

[Domain Location: Policy 1, p 7]
Consulting and advising relationships pie2

Consulting arrangements must include fair market compensation for specific services where compensation reflects time and effort and where expected work products are defined in advance in a written contract.

[Domain Location: Policy 1, p 3]
Access of pharmaceutical sales representatives pie2

Pharmaceutical representatives are allowed to meet with faculty and trainees but the meetings must take place only in non-patient care areas and the meetings must take place by appointment only.

[Domain Location: Policy 1, p 4]
Access of medical device representatives pie3

Access by device manufacturer representatives to patient care areas is permitted by appointment or invitation by faculty members or clinic supervisors. Interactions with faculty must be limited to in-service training or assistance on devices and equipment

[Domain Location: Policy 1, p 4]
Conflict of interest disclosure pie3

Clinical personnel must disclose industry relationships to the university, to students/trainees, to patients, and to the public.

[Domain Location: Policy 1, p 8]
COI curriculum pie3

The Yale medical school bulletin lists a 'Professional Responsibility' course, which, according to material provided to AMSA in 2010 comprehensively covers topics related to conflicts of interest. In addition, there is a course called 'Responsible Conduct

[Domain Location: http://www.yale.edu/printer/bulletin/htmlfiles/med/departments-and-sections.html]
Extension of COI policies to community affiliates pie2

This Policy applies to all physicians, PAs, APRNs, RNs, midwives, or other clinicians who practice in the Yale Medical Group. The Yale Medical Group encompasses many clinical sites on and off the Yale campus.

[Domain Location: Policy 1, p 2]
Enforcement and Sanctions of Policies pie3

There is a party responsible for general oversight to ensure compliance with COI policies and there are sanctions for noncompliance.

[Domain Location: Policy 1, p 9]
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior